Research on innovative hrs-pharma tech. For drug development, based on rapid high resolution screening (hrs) of mixtures with thousands of compounds, resulting in more and higher quality drug candidates and allowing research into 'awkward' pharmaceutical targets.
Bioactive alginates (low guluronate) to be produced in-vivo in bacteria, and by in-vitro epimerisation of high mannuronate alginates from seaweed or bacteria. They will be used for wound healing, health supportive fish feed, fish vaccines and also combined with biopolymers for enhanced performance.
To develop a robust point of care test for monitoring the effect of cancer therapy, based on antibodies directed to a patented peptide involved in cell proliferation.
The photochemical internalisation (pci) technology will be used for site-specific enhancement of the therapeutic effect of anti-cancer drugs in a clinical trial on patients with head, neck and other types of cancer
The project will develop a new technology platform integrating photonic crystals with new laser technology using gan. To illustrate the power of the technology, we will develop a prototype of a new medical device for early detection of cancer.
Together with the lgtc lab at the lumc and the bradley group at the university of edinburgh, flexgen wishes to develop a technology platform for oligonucleotide synthesis. This platform enables multiple core-labs around the world to manufacture low-cost arrays for research purposes.
This arterial function (art.Function) project will research and develop novel vascular models and methods for the simultaneous assessment of biomechanical parameters and blood flow velocity for complete, non-invasive, fast and cost-effective determination of individual vascular function.
Development of aav5-gdnf gene technology platform for brain diseases, focusing in this project on proof of concept for huntington disease and multiple system atrophy.
To develop blot processing system for laboratories performing diagnosis by hybridisation of nucleic acids. The machine will offer solution for automatisation of blot processing together with hybridisation. Next part of project is development of automatic elisa washer.
The aim of the project is research, development and preparation technology of nanolayers with antibacterial, antifungal and antiviral effects and methods of application used in the field of veterinary.